SCIENTIFIC REFERENCES

Chiu CH, et al. Neurobiological mechanisms of action of Hericium Erinaceus in Alzheimer's disease. Int J Med Mushrooms. 2013; 15(6): 1-2.

Rossi P, et al. Improving Training Condition Assessment in Endurance Cyclists: Effects of Ganoderma lucidum and Ophiocordyceps sinensis Dietary Supplementation. Evid Based Complement Alternat Med. 2014; 2014: 979613.

Zhang J, et al. The Neuroprotective Properties of Hericium Erinaceus in Glutamate-Damaged Differentiated PC12 Cells and an Alzheimer's Disease Mouse Model. Int J Mol Sci. 2016; 17(11): 1810.

Lai PL, et al. Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. Int J Med Mushrooms. 2013; 15(6): 539-54.

Lee KF, et al. Protective effects of Ganoderma lucidum polysaccharides peptide on injury of cerebral cortical neurons induced by hypoxia/reoxygenation. Zhongguo Zhong Yao Za Zhi. 2002 Dec;27(12):936-8.

Spelman K, et al. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006 Jun;11(2):128-50.

Akihisa T, et al. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum. Chem Biodivers. 2007 Feb;4(2):224-31.

Paterson RR. Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 2006 Sep;67(18):1985-2001.

Tang W, et al. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005 Spring;8(1):53-8.

Zhang Y, et al. Effect of polysaccharide from Ganoderma lucidum on learning and memory ability in mice. Zhongguo Zhong Yao Za Zhi. 2002 Nov;27(11):871-3.

Zhang W, et al. Protective effect of Ganoderma lucidum polysaccharide on lipopolysaccharide-induced injury of primary cultured hippocampal neurons. Zhongguo Zhong Yao Za Zhi. 2005 Jun;30(12):935-7.

Zhao HB, et al. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med. 2012; 2012: 809614.

Zhou Y, et al. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci Lett. 2008 Jul 18;447(1):31-6.

Wang SQ. Ganoderma lucidum extract protects dopaminergic neurons from oxidative injury. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Jul;15(7):435-7.

Chu QP, et al. Extract of Ganoderma lucidum potentiates pentobarbital-induced sleep via a GABAergic mechanism. Pharmacol Biochem Behav. 2007 Apr;86(4):693-8.

Meir P. Reishi or Ling Zhi (Ganoderma lucidum). Packer L, Ong CN, Halliwell B. Herbal and Traditional Medicine: Molecular Aspects of Health. New York: Marcel Dekker, Inc; 2004:603-622.

Zhu XL, et al. Effects of Hericium Erinaceus on blood glucose levels and nerve cell apoptosis in cerebral ischemia reperfusion injury rat model. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Mar;32(3):370-3.

Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium Erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Int J Med Mushrooms. 2009;11(4):1-2.

Frank Jessen, Prediction of Dementia by Subjective Memory Impairment: Effects of Severity and Temporal Association with Cognitive Impairment. Arch Gen Psychiatry, 2010; 67(4): 414-422.

Koliatsos, V. E., Clatterbuck, R. E., Nauta, H. J., Knüsel, B., Burton, L. E., Hefti, F. F., Mobley, W. C., & Price, D. L. (1991). Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Annals of Neurology, 30(6), 831-840.

Hirokazu Kawagishi, Cun Zhuang, Ellen Shnidman "The Anti-Dementia effect of Yamabushitake Mushroom and Its Clinical Application". Townsendletter.com — April, 2004.

Kawagishi, H., Ando, M., Sakamoto, H., Yoshida S., Ojima, F., Ishiguro, Y., Ukai, N., Fukukawa, S. 1991. "Hericenone C, D and E, Stimulators of Nerve Growth Factor (NGF) Synthesis from the Mushroom Hericium Erinaceum." Tetrahedron Lett 32, 4561-4564.

Ma, Bing-Ji , Jin-Wen Shen, Hai-You Yu, Yuan Ruan, Ting-Ting Wu & Xu Zhao, 2010. "Hericenones and Erinacines: Stimulators of Nerve Growth Factor (NGF) Biosynthesis In Hericium Erinaceus." Mycology: An International Journal on Fungal Biology. 1(2): 92-98.

Li, I. C., Lee, L. Y., Tzeng, T. T., Chen, W. P., Chen, Y. P., Shiao, Y. J., & Chen, C. C. (2018). Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines. Behavioural Neurology, 2018, 5802634.

Mori, K., Inatomi, S., Ouchi, K. Azumi, Y and Tuchida T. 2009. "Improving Effects Of The Mushroom Hericium Erinaceus on Mild Cognitive Impairment: A Double-Blinded, Placebo-Controlled Clinical Trial." Phytother Res. 23:367-372.

Mori, K., Obara, Y., Moriya, T., Inatomi, S., Nakahata, N. 2011. "Effects of Hericium Erinaceus on Amyloid Β(25-35) Peptide-Induced Learning and Memory Deficits in Mice." Biomed Res. 2011 Feb; 32(1):67-72

Ken Babal, C.N. (2018). Anti-Dementia and Beyond: Amyloban & Hericenones Applications Expanded. BIORESEARCH UPDATE NEWS LETTER #3 Anti-Dementia and Beyond

Phan, C. W., David, P., & Sabaratnam, V. (2017). Edible and Medicinal Mushrooms: Emerging Brain Food for the Mitigation of Neurodegenerative Diseases. Journal of Medicinal Food, 20(1), 1-10.

Roberts, R. O., Roberts, L. A., Geda, Y. E., Cha, R. H., Pankratz, V. S., O'Connor, H. M., Knopman, D. S., & Petersen, R. C. (2012). Relative intake of macronutrients impacts risk of mild cognitive impairment or dementia. Journal of Alzheimer's Disease, 32(2), 329-339.

Francis, P. T., Ramírez, M. J., & Lai, M. K. (2010). Neurochemical basis for symptomatic treatment of Alzheimer's disease. Neuropharmacology, 59(4-5), 221-229.

Geng, P., Siu, K. C., Wang, Z., & Wu, J. Y. (2017). Antifatigue Functions and Mechanisms of Edible and Medicinal Mushrooms. BioMed Research International, 2017, 9648496.

Kozarski, M., Klaus, A., Jakovljevic, D., Todorovic, N., Vunduk, J., Petrović, P., Niksic, M., Vrvic, M. M., & van Griensven, L. (2015). Antioxidants of Edible Mushrooms. Molecules, 20(10), 19489-19525.

Huang, Y., Xu, J., Zheng, Y., Hou, B., Liu, Y., Wang, J., & Chen, C. (2021). Cordycepin prevents oxidative stress-induced inhibition of osteogenesis. Scientific Reports, 11, 6551.

Peng, Y., Huang, K., Shen, L., Tao, Y., Xu, T., & Chen, W. (2018). Mechanism of Cordyceps Polypeptide Preventing Learning and Memory Impairment in Scopolamine-Induced Amnesia Mice Model. Evidence-Based Complementary and Alternative Medicine, 2018, 9419264.

Wallace, T. C., & Blusztajn, J. K. (2019). Choline: The Underconsumed and Underappreciated Essential Nutrient. Nutrition Today, 54(6), 258-270.

Liao, L., He, Y., Li, L., Meng, H., Dong, Y., Yi, F., & Xiao, P. (2018). A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide. Chinese Medicine, 13, 57.

Levi-Montalcini, R., & Calissano, P. (1979). The Nerve-Growth Factor. Scientific American, 240(6), 68-77

Vitrafoxin Label